NASDAQ Companies

– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim […]

BURLINGTON, Mass. and JERUSALEM, June 10, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), […]

FORT MYERS, Fla., June 10, 2024 (GLOBE NEWSWIRE) — American Oncology Network, Inc.  (AON) (OTCQX: AONC), a rapidly-growing network of […]

SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, […]

UTRECHT, The Netherlands and PHILADELPHIA, June 10, 2024 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology […]

Interim results of REGEN-007 Phase 2 trial show stabilization of kidney function for 18 months Safety profile consistent with prior […]

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million […]

Improvements in multiple sign efficacy endpoints were observed in full population and with predictive and more pronounced effects in the […]

Berlin and Kyiv, 10 June 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged […]

CHATTANOOGA, Tenn., June 10, 2024 (GLOBE NEWSWIRE) — Food Logistics named Covenant Logistics Group as one of the winners of […]